Product Information

ZIPRASIDONE HCL 40 MG CAPSULE is a generic product labeled by BluePoint Laboratories, priced at $0.2648 per EA under NDC 68001045106. Its NADAC has been published 297 times since Mar 10, 2021.

FDA first approved this application on Dec 27, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ZIPRASIDONE HCL 40 MG CAPSULE

Ziprasidone Hydrochloride
$0.2648per EA

Strength

40 mg/1

NDC

68001045106

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ZIPRASIDONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204117

FDA Approved

12/27/2016

TE Code

AB

On Market Since

8/31/2020

Pharmacological Classes

Price Statistics

The NADAC for ZIPRASIDONE HCL 40 MG CAPSULE has been published 297 times since Mar 10, 2021, and over the history we have for it it has declined 12.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2648 per EA
All-time high$0.3802 (Jun 16, 2021)
All-time low$0.1879 (Nov 20, 2024)
52-week high$0.2786
52-week low$0.2548
Median price$0.2759
Average price$0.2764
Largest weekly change+30.8% (Jun 19, 2024)
Weeks tracked297
Tracking sinceMar 10, 2021

Price History

1W

0.0%

1M

-2.7%

3M

-1.1%

6M

-4.7%

1Y

+2.6%

3Y

-1.8%

5Y

-2.0%

All

-12.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ZIPRASIDONE HCL 40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ZIPRASIDONE HCL 40 MG CAPSULE, manufactured by BluePoint Laboratories, is $0.2648 per EA (NDC 68001045106), effective Nov 11, 2026.

How has the price of ZIPRASIDONE HCL 40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ZIPRASIDONE HCL 40 MG CAPSULE has declined 12.0%. It has been tracked across 297 weekly CMS publications since Mar 10, 2021.

What are the highest and lowest recorded NADAC prices for ZIPRASIDONE HCL 40 MG CAPSULE?

Since Mar 10, 2021, the NADAC for ZIPRASIDONE HCL 40 MG CAPSULE has ranged from a low of $0.1879 (Nov 20, 2024) to a high of $0.3802 (Jun 16, 2021), with a median of $0.2759 per EA.

Are there cheaper alternatives to ZIPRASIDONE HCL 40 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ZIPRASIDONE HCL 40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures ZIPRASIDONE HCL 40 MG CAPSULE?

ZIPRASIDONE HCL 40 MG CAPSULE (NDC 68001045106) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.